in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Informex 2013: Bright outlook for US API manufacturing
9:47 AM MST | March 1, 2013 | —Rebecca Coons in Anaheim
Drug companies looking for fast turnaround and strong intellectual property (IP) protection are moving away from low-cost emerging market firms—lifting prospects for US-based producers of active pharmaceutical ingredients (APIs) producers, according to attendees of Informex, held earlier this month at Anaheim, CA....
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee